KK
Kareshma Khanna
About Kareshma Khanna
Data last updated:
Kareshma Khanna is a Director at Sri Harkrishan Colonisers & Promoters Private Limited (since 2018) and Director at Cure Meds Private Limited (since 2018). The companies operate in Real Estate and Healthcare. The 2 current companies with reported revenue have a combined latest revenue of ₹77 Lakh; the largest is Sri Harkrishan Colonisers & Promoters Private Limited at ₹38.5 Lakh (FY 2020).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 31 Jul 2018 | 2007 | ₹38.5 Lakh (FY 2020) | Active | |
| Director | 31 Jul 2018 | 2015 | ₹38.5 Lakh (FY 2025) | Active |
Board colleagues of Kareshma Khanna
| Name | DIN | Company | Designation |
|---|---|---|---|
| Seema Khanna | 05132950 | Sri Harkrishan Colonisers & Promoters Private Limited , Cure Meds Private Limited | Director |
| Pranav Agarwal | 03584295 | Cure Meds Private Limited | Additional Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Kareshma Khanna
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Kareshma Khanna
Kareshma Khanna currently holds 2 directorships: Sri Harkrishan Colonisers & Promoters Private Limited (Director, since 31 Jul 2018, revenue ₹38.5 Lakh (FY 2020)); Cure Meds Private Limited (Director, since 31 Jul 2018, revenue ₹38.5 Lakh (FY 2025)).
Kareshma Khanna was first appointed on 31 Jul 2018 as Director at Sri Harkrishan Colonisers & Promoters Private Limited.
The 2 current companies of Kareshma Khanna that report revenue have a combined latest revenue of ₹77 Lakh: Sri Harkrishan Colonisers & Promoters Private Limited ₹38.5 Lakh (FY 2020); Cure Meds Private Limited ₹38.5 Lakh (FY 2025).
The current boards of Kareshma Khanna's companies include Seema Khanna (Sri Harkrishan Colonisers & Promoters Private Limited), Pranav Agarwal (Cure Meds Private Limited).